4//SEC Filing
NEIL GARRY ARTHUR 4
Accession 0001628280-22-026158
CIK 0001534120other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 4:03 PM ET
Size
5.4 KB
Accession
0001628280-22-026158
Insider Transaction Report
Form 4
NEIL GARRY ARTHUR
Chief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-10-05+75,000→ 75,000 totalExercise: $3.97From: 2023-10-05Exp: 2032-10-05→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The stock option will vest in full on October 5, 2023, subject to the Reporting Person's continued service on such vesting date.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001586785
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 4:03 PM ET
- Size
- 5.4 KB